135 related articles for article (PubMed ID: 699958)
21. Regional distribution and production rate of 3-methoxy-4-hydroxyphenylethyleneglycol sulphate (MHPG-SO4) in rat brain.
Kohno Y; Tanaka M; Nakagawa R; Toshima N; Nagasaki N
J Neurochem; 1981 Jan; 36(1):286-9. PubMed ID: 7463053
[TBL] [Abstract][Full Text] [Related]
22. [Effect of chronic desipramine treatment on rat brain adrenergic alpha 2-receptor].
Sekiya Y; Sugita R; Naitoh H; Kunimi Y; Nomura S
Yakubutsu Seishin Kodo; 1991 Aug; 11(4):245-55. PubMed ID: 1665932
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiological and biochemical responses of noradrenergic neurons to a non-amphetamine CNS stimulant.
German DC; Sanghera MK; Kiser RS; McMillen BA; Shore PA
Brain Res; 1979 Apr; 166(2):331-9. PubMed ID: 427592
[TBL] [Abstract][Full Text] [Related]
24. Interaction of antidepressants with clonidine on rat brain total 3-methoxy-4-hydroxyphenylglycol.
Tang SW; Helmeste DM; Stancer HC
Can J Physiol Pharmacol; 1979 Apr; 57(4):435-7. PubMed ID: 455145
[TBL] [Abstract][Full Text] [Related]
25. Receptor dynamics: effect of repeated administration of desmethylimipramine on the noradrenergic systems in rat brain.
Bürki HR; Rüdeberg C; Taimisto EL
Postgrad Med J; 1981; 57 Suppl 1():71-6. PubMed ID: 6272253
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine.
Mann CD; Vu TB; Hrdina PD
Br J Pharmacol; 1995 Jun; 115(4):595-600. PubMed ID: 7582477
[TBL] [Abstract][Full Text] [Related]
27. On the origin of vanillylmandelic acid and 3-methoxy-4-hydroxy-phenylglycol in the rat brain.
Adèr JP; Muskiet FA; Jeuring HJ; Korf J
J Neurochem; 1978 Jun; 30(6):1213-6. PubMed ID: 670965
[No Abstract] [Full Text] [Related]
28. Determination of normetanephrine, 3,4-dihydroxyphenylethyleneglycol (free and total), and 3-methoxy-4-hydroxyphenylethyleneglycol (free and total) in rat brain by high-performance liquid chromatography with electrochemical detection and effects of drugs on regional concentrations.
Westerink BH
J Neurochem; 1984 Apr; 42(4):934-42. PubMed ID: 6699645
[TBL] [Abstract][Full Text] [Related]
29. Effects of piribedil on noradrenaline and MOPEG-SO4 levels in the rat brain.
Garattini S; Bareggi SR; Marc V; Calderini G; Morselli PL
Eur J Pharmacol; 1974 Sep; 28(1):214-6. PubMed ID: 4430323
[No Abstract] [Full Text] [Related]
30. Beta-adrenoceptor mediated inhibition of behavioral action of desipramine and of central noradrenergic activity in forced swimming rats.
Miyauchi T; Kitada Y; Nakamichi H; Satoh S
Life Sci; 1984 Jul; 35(5):543-51. PubMed ID: 6748862
[TBL] [Abstract][Full Text] [Related]
31. Tetrabenazine-induced depletion of brain monoamines: mechanism by which desmethylimipramine protects cortical norepinephrine.
Pettibone DJ; Pflueger AB; Totaro JA
Eur J Pharmacol; 1984 Jul; 102(3-4):431-6. PubMed ID: 6149131
[TBL] [Abstract][Full Text] [Related]
32. Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment.
Garcia AS; Barrera G; Burke TF; Ma S; Hensler JG; Morilak DA
J Neurochem; 2004 Nov; 91(3):683-93. PubMed ID: 15485498
[TBL] [Abstract][Full Text] [Related]
33. Increased brain norepinephrine metabolism correlated with analgesia produced by the periaqueductal gray injection of opiates.
Reigle TG
Brain Res; 1985 Jul; 338(1):155-9. PubMed ID: 4027585
[TBL] [Abstract][Full Text] [Related]
34. Further studies of the effects of morphine on the levels of MHPG-SO4 in rat brain.
Roffman M; Reigle T; Orsulak P; Cassens G; Schildkraut JJ
Neuropharmacology; 1979 May; 18(5):483-7. PubMed ID: 460544
[No Abstract] [Full Text] [Related]
35. Interaction of triazolam with desipramine. Effects of single and repeated treatment on certain pharmacologic responses and brain catecholamine levels.
Kusaka M; Horikawa A; Meshi T; Maruyama Y
Psychopharmacology (Berl); 1980; 70(3):255-61. PubMed ID: 6108590
[TBL] [Abstract][Full Text] [Related]
36. The effect of propranolol on blood pressure and central MOPEG concentration in the conscious spontaneously hypertensive rat.
Keeton TK; Hall JS
Eur J Pharmacol; 1986 Jun; 125(2):293-6. PubMed ID: 3743639
[TBL] [Abstract][Full Text] [Related]
37. Effects of acute morphine administration on noradrenaline turnover and metabolism in various brain parts of control and handled rats.
Attila LM
Pharmacol Toxicol; 1989 Feb; 64(2):202-9. PubMed ID: 2755921
[TBL] [Abstract][Full Text] [Related]
38. Specific and sensitive radioimmunoassay for 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG).
Keeton TK; Krutzsch H; Lovenberg W
Science; 1981 Feb; 211(4482):586-8. PubMed ID: 7455697
[TBL] [Abstract][Full Text] [Related]
39. Effect of pergolide on MOPEG sulphate levels in rat brain regions.
Fuller RW; Perry KW
J Pharm Pharmacol; 1983 Jan; 35(1):57-8. PubMed ID: 6131970
[No Abstract] [Full Text] [Related]
40. Gangliosides enhance behavioral and neurochemical effects induced by chronic desipramine (DMI) treatment.
Molina VA; Keller EA; Orsingher OA
Eur J Pharmacol; 1989 Jan; 160(2):247-52. PubMed ID: 2547628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
